TEMOZOLOMIDE 250 mg Pill - gray & white capsule-shape, 22mm
Pill with imprint TEMOZOLOMIDE 250 mg is Gray & White, Capsule-shape and has been identified as Temozolomide 250 mg. It is supplied by Mayne Pharma US.
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEMOZOLOMIDE 250 mg
Temozolomide
- Imprint
- TEMOZOLOMIDE 250 mg
- Strength
- 250 mg
- Color
- Gray & White
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mayne Pharma US
- Manufacturer
- IDT Australia Limited
- National Drug Code (NDC)
- 51862-0088 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
sodium starch glycolate type A potato,
silicon dioxide,
stearic acid,
tartaric acid,
gelatin,
methylparaben sodium,
propylparaben sodium,
sodium lauryl sulfate,
ferrosoferric oxide,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "TEMOZOLOMIDE 250 mg"
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Drug Information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.